Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in thousands)
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14 | 9 | 112 | 1,056 | 845 |
| Receivables | 294 | 514 | 65 | 319 | 869 |
| Inventories | 1,054 | 1,047 | 0 | 1,149 | 825 |
| TOTAL | $1,377 | $1,611 | $201 | $2,745 | $3,055 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 0 | 356 | 526 |
| Intangibles | 0 | 0 | 0 | 934 | 9,868 |
| Other Non-Current Assets | 0 | 0 | 0 | 24 | 24 |
| TOTAL | $2 | $2 | $0 | $1,314 | $10,417 |
| Total Assets | $1,378 | $1,612 | $201 | $4,059 | $13,472 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 466 | 316 | 420 | 321 | N/A |
| Accrued Expenses | 48 | 48 | 57 | 66 | N/A |
| TOTAL | $514 | $364 | $1,097 | $608 | $635 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26 | 310 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 55 |
| TOTAL | $26 | $310 | $0 | $310 | $276 |
| Total Liabilities | $540 | $674 | $1,097 | $918 | $911 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,739 | N/A | N/A | N/A | N/A |
| Common Shares | 51,038 | 50,520 | 0 | 49,153 | 46,510 |
| Retained earnings | -57,209 | -56,518 | -896 | -52,865 | -41,498 |
| Other shareholders' equity | 6,418 | 6,346 | 0 | 6,278 | 7,041 |
| TOTAL | $838 | $939 | $-896 | $3,141 | $12,561 |
| Total Liabilities And Equity | $1,378 | $1,612 | $201 | $4,059 | $13,472 |